araldite-2011-sds

SAFETY DATA SHEET According to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 ARALDITE® 2011 RESIN

Version 1 . 3

Revision Date: 27.09.2021

SDS Number: 400001015903

Date of last issue: 15.06.2018 Date of first issue: 23.01.2018

Print Date 14.09.2022

Frequency of Treatment: 7 days/week No observed adverse effect level: 15 mg/kg bw/day Method: OECD Test Guideline 453 Result: negative Target Organs: Digestive organs

Species: Mouse, male Application Route: Dermal Exposure time: 24 month(s)

Dose: 0, 0.1, 10, 100 mg/kg bw/day Frequency of Treatment: 3 days/week No-observed-effect level: 0.1 mg/kg body weight Method: OECD Test Guideline 453 Result: negative Target Organs: Digestive organs

Species: Rat, female Application Route: Dermal Exposure time: 24 month(s)

Dose: 0.1, 100, 1000 mg/kg bw/day Frequency of Treatment: 5 days/week No-observed-effect level: 100 mg/kg body weight Method: OECD Test Guideline 453 Result: negative

Species: Rat, female Application Route: Oral Exposure time: 24 month(s)

Dose: 0, 2, 15, or 100 mg/kg bw/day Frequency of Treatment: 7 days/week No observed adverse effect level: 100 mg/kg bw/day Method: OECD Test Guideline 453 Result: negative Target Organs: Digestive organs

Species: Rat, females Application Route: Oral Exposure time: 24 month(s)

Dose: 0, 2, 15, or 100 mg/kg bw/day Frequency of Treatment: 7 days/week No-observed-effect level: 2 mg/kg bw/day Method: OECD Test Guideline 453 Result: negative Target Organs: Digestive organs

Bisphenol A - epoxy resins, number average MW >700 - <1100 : Species: Rat, male and female Application Route: Oral Exposure time: 24 month(s) Dose: 15 mg/kg

Frequency of Treatment: 7 daily Method: OECD Test Guideline 453 Result: negative

Carcinogenicity -

: No data available

SDS_GB-AM – 6N – 400001015903

15 / 28